{"id":"NCT06025695","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks","officialTitle":"A Phase III, Observer-blind, Randomized, Multicenter Study to Evaluate Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid as Compared to GSK's Rotarix Liquid, Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-09-01","primaryCompletion":"2024-05-28","completion":"2024-10-23","firstPosted":"2023-09-06","resultsPosted":"2025-05-09","lastUpdate":"2025-05-09"},"enrollment":2000,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Gastroenteritis"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"GSK's liquid oral live attenuated HRV","otherNames":["Rotarix"]},{"type":"COMBINATION_PRODUCT","name":"PCV-free liquid formulation of GSK's oral live attenuated HRV","otherNames":["Rotarix PCV-free"]}],"arms":[{"label":"Human Rotavirus (HRV) Group","type":"ACTIVE_COMPARATOR"},{"label":"HRV Porcine Circovirus (PCV)-free Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the immunogenicity, reactogenicity and safety of the Porcine circovirus (PCV)-free liquid formulation of GlaxoSmithKline Biologicals' SA (GSK) oral live attenuated human rotavirus (HRV) study intervention compared to GSK's liquid oral live attenuated HRV study intervention in healthy Chinese infants 6 to 16 weeks of age at the time of the first study intervention administration.","primaryOutcome":{"measure":"Percentage of Participants With Anti-rotavirus (RV) Immunoglobulin A (IgA) Antibody (Ab) Seroconversion Rate","timeFrame":"At Month 2 (1-month post-Dose 2)","effectByArm":[{"arm":"Human Rotavirus (HRV) Group","deltaMin":88.7,"sd":null},{"arm":"HRV Porcine Circovirus (PCV)-Free Group","deltaMin":84.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":12,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":251,"n":998},"commonTop":["Respiratory tract infection","Pyrexia","Irritability","Diarrhoea","Decreased appetite"]}}